UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMPD
5751
Empery Digital
EMPD
$89.5M
| $932K | ﹤0.01% |
261,824
-265,927
| -50% | -$1.19M |
|
5752
Clean Energy Fuels
CLNE
$379M
| $932K | ﹤0.01% |
454,523
+112,920
| +33% | +$240K |
|
5753
Cerence
CRNC
$357M
| $930K | ﹤0.01% |
82,127
+2,733
| +3% | +$26.8K |
|
5754
PUT
Capri Holdings
CPRI
$1.7B
| $929K | ﹤0.01% |
+50,000
| New | +$960K |
|
5755
CALL
XPeng
XPEV
$10.2B
| $927K | ﹤0.01% |
70,000
-1,797,145
| -96% | -$28.5M |
|
|
5756
PUT
XPeng
XPEV
$10.2B
| $927K | ﹤0.01% |
70,000
-660,000
| -90% | -$10.5M |
|
5757
ECARX Holdings
ECX
$409M
| $926K | ﹤0.01% |
718,091
+35,961
| +5% | +$41K |
|
5758
Horizon Technology Finance
HRZN
$310M
| $925K | ﹤0.01% |
195,466
+51,330
| +36% | +$222K |
|
|
IGA
5759
Voya Global Advantage and Premium Opportunity Fund
IGA
$163M
| $924K | ﹤0.01% |
93,322
-1,914
| -2% | -$18.5K |
|
|
FRMM
5760
Forum Markets
FRMM
$60.7M
| $921K | ﹤0.01% |
169,656
-158,138
| -48% | -$691K |
|
5761
Five Star Bancorp
FSBC
$1.1B
| $921K | ﹤0.01% |
18,917
-9,856
| -34% | -$416K |
|
5762
VEON
VEON
$4.75B
| $921K | ﹤0.01% |
17,636
+419
| +2% | +$21.8K |
|
|
OSG
5763
Octave Specialty Group
OSG
$202M
| $919K | ﹤0.01% |
147,197
-117,083
| -44% | -$610K |
|
5764
Barron's 400 ETF
BFOR
$228M
| $918K | ﹤0.01% |
38,404
-2,228
| -5% | -$49.9K |
|
|
MTLS
5765
Materialise
MTLS
$442M
| $916K | ﹤0.01% |
123,225
+61,692
| +100% | +$365K |
|
|
ATYR
5766
aTyr Pharma
ATYR
$35.3M
| $914K | ﹤0.01% |
1,531,151
-2,336,062
| -60% | -$1.53M |
|
|
TBCH
5767
Turtle Beach Corp
TBCH
$225M
| $914K | ﹤0.01% |
73,420
+43,698
| +147% | +$518K |
|
|
HUYA
5768
Huya Inc
HUYA
$470M
| $914K | ﹤0.01% |
397,309
+38,642
| +11% | +$110K |
|
|
CCD
5769
Calamos Dynamic Convertible & Income Fund
CCD
$666M
| $911K | ﹤0.01% |
35,370
-86,674
| -71% | -$2.12M |
|
5770
Caribou Biosciences
CRBU
$140M
| $911K | ﹤0.01% |
517,371
+258,202
| +100% | +$510K |
|
5771
ProShares UltraShort QQQ
QID
$232M
| $910K | ﹤0.01% |
67,157
-9,798
| -13% | -$158K |
|
5772
CALL
Invesco NASDAQ 100 ETF
QQQM
$105B
| $909K | ﹤0.01% |
3,000
-510
| -15% | -$144K |
|
5773
The Honest Company
HNST
$572M
| $909K | ﹤0.01% |
248,333
-455,748
| -65% | -$1.54M |
|
5774
MiMedx Group
MDXG
$682M
| $909K | ﹤0.01% |
236,033
-436,969
| -65% | -$1.59M |
|
5775
BrightSpring Health Services Unit
BTSGU
$1.5B
| $908K | ﹤0.01% |
3,967
+623
| +19% | +$114K |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.